Insider Stock Trading History of Adelman Daniel C Md


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Adelman Daniel C Md since year 2005. The trader's CIK number is 1222037. At the time of this reporting, Adelman Daniel C Md is the Chief Medical Officer of Aimmune Therapeutics, Inc. . (stock ticker symbol AIMT). See this page for all insider trading activities at Aimmune Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Adelman Daniel C Md since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-16 AIMT Aimmune Therapeutics, Inc. Sale 9,933 40.00 397,320
2018-01-12 AIMT Aimmune Therapeutics, Inc. Option Ex 26,784 11.45 306,676
2018-01-12 AIMT Aimmune Therapeutics, Inc. Sale 26,784 40.00 1,071,360
2018-01-16 AIMT Aimmune Therapeutics, Inc. Option Ex 9,933 11.45 113,732
2017-12-27 AIMT Aimmune Therapeutics, Inc. Sale 3,283 40.00 131,320
2017-12-27 AIMT Aimmune Therapeutics, Inc. Option Ex 3,283 11.45 37,590
2017-10-23 AIMT Aimmune Therapeutics, Inc. Sale 10,000 34.33 343,260
2017-10-23 AIMT Aimmune Therapeutics, Inc. Option Ex 10,000 11.45 114,500
2017-09-25 AIMT Aimmune Therapeutics, Inc. Option Ex 10,000 11.45 114,500
2017-09-25 AIMT Aimmune Therapeutics, Inc. Sale 10,000 25.00 250,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adelman Daniel C Md (Chief Medical Officer of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.